Fundz

Prelude Corporation Appoints Dr. Pat Whitworth as Chief Medical Officer

PUBLIC · PRLDMay 02, 2024

Position

Chief Medical Officer

Company

Prelude

Pat Whitworth
pwhitworth@preludedx.com
WilmingtonInformation TechnologyBiotechnologySustainabilitySoftwareHealth CarePrivacy And SecurityFintechBiotechnology Research

Description

Prelude Corporation (PreludeDx®) announced the appointment of Dr. Pat Whitworth as its new Chief Medical Officer.

Quick answer

Prelude Corporation Appoints Dr. Pat Whitworth as Chief Medical Officer (May 2, 2024). Prelude is based in Wilmington, Delaware, United States.

Who is the new Chief Medical Officer at Prelude?
Prelude named Pat Whitworth Chief Medical Officer, announced May 2, 2024.
What did Prelude announce on May 2, 2024?
Prelude Corporation (PreludeDx®) announced the appointment of Dr. Pat Whitworth as its new Chief Medical Officer.
What does Prelude do?
PreludeDx is a precision diagnostics company dedicated to providing actionable tools for managing early-stage breast cancer.
Where is Prelude based?
Prelude is based in Wilmington, Delaware, United States.
Which similar companies made leadership changes around the same time?
Electra Therapeutics (May 1, 2024), Odysight.ai (May 6, 2024), YS Biopharma (May 7, 2024) and Zephyr AI, Inc. (May 16, 2024) also announced leadership changes within 45 days of Prelude.

Source: Fundz verified event record.

Other recent leadership changes in Sustainability and Privacy And Security

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Prelude, and when

A new leader at Prelude brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Prelude raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Prelude, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Prelude. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Prelude

Location

Wilmington, Delaware, United States

About

PreludeDx is a precision diagnostics company dedicated to providing actionable tools for managing early-stage breast cancer. Its first test, DCISionRT, is the result of over a decade of research focused on DCIS and was developed using technology licensed from the University of California, San Francisco. Designed to address the critical question faced by DCIS patients — What is my risk of recurrence, and what treatment is appropriate? — DCISionRT helps personalize treatment decisions with confidence.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Prelude changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Paul-Louis
Likely contact at this company
••••••••@••••••••

See Paul-Louis's verified email →

Dan
Senior decision-maker at this company
••••••••@••••••••

See Dan's verified email →

Chris
Senior decision-maker at this company
••••••••@••••••••

See Chris's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Prelude's next move

Learn about Strategic plan

Prelude changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.